Literature DB >> 1081656

Influence of L-3-methoxytyrosine on monoamine synthesis in rat brain.

W Kehr.   

Abstract

Rats were injected i.p. with L-3-methoxytyrosine, 100 or 300 mg/kg. One h later brain, liver, heart and blood plasma were analyzed for catecholamines and their precursors. In brain Dopa as well as dopamine and noradrenaline levels were unchanged, while demethylation of L-3-methoxytyrosine might have occurred in peripheral organs since Dopa levels in liver and dopamine in heart were elevated. 3-Methoxytyramine could not be detected in brain and liver after treatment with L-3-methoxytyrosine. Monoamine synthesis in vivo was measured in whole brain by determining the accumulation of Dopa and 5-hydroxytryptophan 30 min after the i.p. injection of NSD 1015(3-hydroxybenzylhydrazine HC1, 100 mg/kg), an inhibitor of the aromatic amino acid decarboxylase. L-3-Methoxytyrosine attenuated the formation of Dopa and 5-hydroxytryptophan by about 25% in brain tissue. The effect was paralleled by a decrease in the brain concentration of tryptophan.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1081656     DOI: 10.1007/bf00499948

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  31 in total

1.  Dynamic aspects of enzymatic O-methylation and -demethylation of catechols in vitro and in vivo.

Authors:  J W DALY; J AXELROD; B WITKOP
Journal:  J Biol Chem       Date:  1960-04       Impact factor: 5.157

2.  Effects of L-dopa and L-3-methoxytyrosine on D-methamphetamine-induced motor activity and seizures induced by electroshock.

Authors:  J R McLean; C R Ensor; D A McCarthy; B Bohner; D Potoczak
Journal:  Proc Soc Exp Biol Med       Date:  1973-09

3.  3-O-methyldopa, a new precursor of dopamine.

Authors:  G Bartholini; I Kuruma; A Pletscher
Journal:  Nature       Date:  1971-04-23       Impact factor: 49.962

4.  The determination of dopamine by a modification of the dihydroxyindole fluorimetric assay.

Authors:  C V Atack
Journal:  Br J Pharmacol       Date:  1973-08       Impact factor: 8.739

5.  [Substitutive therapy in Parkinson's syndromes. L-dopa plus peripheral decarboxylase inhibitor or 3-0-methyl dopa?].

Authors:  G Gauthier; J de Ajuriaguerra; F Geissbuhler; B Simona; J Constantinidis; G Yanniotis; M Krassoievitch; J J Eisenring; R Tissot
Journal:  Presse Med       Date:  1971-01-16       Impact factor: 1.228

6.  A study of 5-hydroxytryptamine formation from L-tryptophan in the brain and other tissues.

Authors:  L J Weber; A Horita
Journal:  Biochem Pharmacol       Date:  1965-07       Impact factor: 5.858

7.  Metabolic fate of l-[14C] DOPA in cerebrospinal fluid and blood plasma of humans.

Authors:  A Pletscher; G Bartholini; R Tissot
Journal:  Brain Res       Date:  1967-02       Impact factor: 3.252

8.  Attempts to measure endogenous levels of dopa and 5-hydroxytryptophan in rat brain.

Authors:  M Lindqvist; W Kehr; A Carlsson
Journal:  J Neural Transm       Date:  1975       Impact factor: 3.575

9.  Evidence that the central action of amphetamine is mediated via catecholamines.

Authors:  L C Hanson
Journal:  Psychopharmacologia       Date:  1966

10.  The effect of reserpine upon the synthesis of norepinephrine in the isolated rabbit heart.

Authors:  C O Rutledge; N Weiner
Journal:  J Pharmacol Exp Ther       Date:  1967-08       Impact factor: 4.030

View more
  2 in total

1.  An improved fluorimetric method for assay of dopa in urine and tissues and its use for determination of urinary dopa, at endogenous level, in different species.

Authors:  J M Cottet-Emard; L Peyrin
Journal:  J Neural Transm       Date:  1977       Impact factor: 3.575

2.  Methoxytyrosine formation as an indicator of catechol-O-methyltransferase activity in rat liver in vivo.

Authors:  W Kehr; R Zimmermann; M Thiede
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-10       Impact factor: 3.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.